Trials / Completed
CompletedNCT03034928
Clinical Biocompatibility Evaluation of Contact Lens Coatings
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 33 (actual)
- Sponsor
- Alcon Research · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The primary objective is to evaluate corneal staining observed after 2 hours of wear with contact lenses with investigational coating against PureVision™ lenses, all pre-cycled with OPTI-FREE® RepleniSH® multi-purpose disinfection solution.
Detailed description
In this contralateral crossover study, qualifying subjects will wear a total of 2 pairs of study contact lenses. Lenses will be worn according to a randomized lens sequence assignment. Each pair will consist of a test lens (Test 1 or Test 2) and a control lens.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Contact lens with investigational coating 1 | Contact lens with investigational coating 1 pre-cycled in OPTI-FREE® RepleniSH® Multi-Purpose Disinfecting Solution (MPDS) |
| DEVICE | Balafilcon A contact lens | Balafilcon A contact lens pre-cycled OPTI-FREE® RepleniSH® MPDS |
| DEVICE | OPTI-FREE® RepleniSH® MPDS | Multipurpose contact lens solution |
| DEVICE | Contact lens with investigational coating 2 | Contact lens with investigational coating 2 pre-cycled in OPTI-FREE® RepleniSH® MPDS |
Timeline
- Start date
- 2017-02-14
- Primary completion
- 2017-03-14
- Completion
- 2017-03-14
- First posted
- 2017-01-27
- Last updated
- 2020-02-18
- Results posted
- 2020-02-18
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT03034928. Inclusion in this directory is not an endorsement.